Matek W, Guggenmoos-Holzmann I, Demling L
Endoscopy. 1985 Sep;17(5):175-81. doi: 10.1055/s-2007-1018494.
With the aim of establishing suitable follow-up intervals, we examined the probability for the recurrence of relevant adenomas in the colorectum. A total of 592 adenoma patients in whom colonoscopy up to the caecum had reliably excluded relevant findings, were admitted to the study. Relevant findings were considered to be 1) colorectal carcinoma, 2) an adenoma with severe cellular atypia, 3) an adenoma of at least 5 mm in diameter, 4) a histologically unclassified polyp of at least 5 mm in diameter. We were able to show that the use of a dose-effect relationship is statistically justified for the follow-up results of the 592 patients. Thus, the probability for renewed relevant findings at any given time can be computed on the basis of the follow-up results. Renewed relevant findings were presented by 6.0% of patients with single adenomas after 4 years (confidence level 4.8-7.3%), while 5.7% of patients with multiple adenomas had relevant findings after 2 years (confidence level 4.5-7.0%). These follow-up intervals are, thanks to the adequate detection rate, economical and, at the same time, safeguard adenoma patients with a high level of reliability, against cancer of the colorectum.
为了确定合适的随访间隔,我们研究了结肠直肠中相关腺瘤复发的可能性。共有592例腺瘤患者纳入本研究,这些患者经结肠镜检查至盲肠,可靠地排除了相关病变。相关病变定义为:1)结肠直肠癌;2)具有严重细胞异型性的腺瘤;3)直径至少5mm的腺瘤;4)直径至少5mm的组织学未分类息肉。我们能够证明,对于这592例患者的随访结果,采用剂量效应关系在统计学上是合理的。因此,可以根据随访结果计算出在任何给定时间再次出现相关病变的概率。单发腺瘤患者4年后有6.0%出现再次相关病变(置信水平4.8 - 7.3%),而多发腺瘤患者2年后有5.7%出现相关病变(置信水平4.5 - 7.0%)。由于检测率足够,这些随访间隔既经济,同时又能高度可靠地保护腺瘤患者预防结肠直肠癌。